Modeling defective interfering virus therapy for AIDS: Conditions for DIV survival
From MaRDI portal
Publication:1804865
Recommendations
Cited in
(5)- No two without three: modeling dynamics of the trio RNA virus-defective interfering genomes-satellite RNAs
- Affinity Hemodialysis for Antiviral Therapy with Specific Application to HIV
- Fighting a virus with a virus: A dynamic model for HIV-1 therapy
- A delayed dynamical model for COVID-19 therapy with defective interfering particles and artificial antibodies
- Quadratic infectious diseases mathematical models: chronic states, sanity levels, and treatment
This page was built for publication: Modeling defective interfering virus therapy for AIDS: Conditions for DIV survival
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1804865)